Gland Pharma: latest news - GoINPHARMA
Tuesday, 22 January 2019 - 4:01

Gland Pharma

China’s big pharma targets India

After acquiring Gland Pharma for $1bn, China-based Fosun Pharmaceutical is reportedly in advanced talks to acquire another Indian company. Fosun is now targeting Symbiotec Pharma, a company focused on steroids, which last year posted revenues of $62m. Symbiotec, subsidiary of…

Chinese fund Fosun successfully acquires Gland Pharma ($1.1bn)

China-based investment fund Fosun has reviewed its $1.3bn offer to India’s drugmaker Gland Pharma, and now plans to buy 74% instead of 86%, in order to bypass Indian authorities, which few months ago blocked the transaction. India’s Committee on Economic…

Indian administration ready to block $1.3bn Fosun-Gland Pharma deal

India’s Government body Cabinet Committee on Economic Affairs, chaired by Prime Minister Narendra Modi, reportedly decided to forbid the China-based investment fund Fosun – owned by Chinese billionaire Guo Guangchang – to carry out the $1.3 billion takeover of India-based…